Descripción general

Select a topic to solve related cases or follow a course topic

• Topic 1
  UPDATED --- Targeted therapies for metastatic UCa in special populations
  Cases CME course
• Topic 2
  Tailoring treatment for metastatic hormone-sensitive prostate cancer
  Cases CME course
• Topic 3
  Finding the right ADT for the right patient
  Cases CME course
• Topic 4
  High-risk non-metastatic prostate cancer
  Cases CME course
• Topic 5
  Management of non-metastatic castration-resistant prostate cancer
  Cases CME course
• Topic 6
  NEW --- Treatment selection in mCRPC patients harbouring HRR gene mutations
  Cases CME course
• Topic 7
  NEW --- Sequencing treatments in mCRPC patients without HRR gene mutations
  Cases CME course
• Topic 8
  High-risk non-metastatic prostate cancer
  Cases CME course
• Topic 9
  Tailoring treatment for metastatic hormone-sensitive prostate cancer
  Cases CME course
• Topic 10
  Finding the right ADT for the right patient
  Cases CME course
• Topic 11
  UPDATED --- First-line therapy of synchronous and metachronous metastatic UCa
  Cases CME course
• Topic 12
  New hope for patients progressing after prior treatment for mUCa
  Cases CME course
• Topic 13
  Handling AEs of targeted therapies for metastatic UCa
  Cases CME course
• Topic 14
  Molecular diagnostics in the era of targeted therapies for mUCa
  Cases CME course
• Topic 15
  Adjuvant treatment approaches for MIBC
  Cases CME course
• Topic 16
  Histological subtypes of (N)MIBC: managed differently compared to pure UCa?
  Cases CME course
• Topic 17
  Initial treatment of MIBC
  Cases CME course
• Topic 18
  Follow-up surveillance regimes to consider for (very) high-risk NMIBC and MIBC
  Cases CME course
• Topic 19
  Follow-up surveillance regimes for low-/intermediate-risk NMIBC
  Cases CME course
• Topic 20
  Low- and intermediate-risk NMIBC: surveillance or intravesical therapy?
  Cases CME course
• Topic 21
  Systemic therapy for HER2-positive early breast cancer
  Cases CME course
• Topic 22
  First-line systemic therapy in metastatic renal cell carcinoma
  Cases CME course
• Topic 23
  Systemic therapy for mRCC: second line and beyond
  Cases CME course
• Topic 24
  Adjuvant systemic treatment of luminal A/B early breast cancer in premenopausal women
  Cases CME course
• Topic 25
  Adjuvant systemic treatment of luminal A/B early breast cancer in postmenopausal women
  Cases CME course
• Topic 26
  Management of small renal masses
  Cases CME course
• Topic 27
  Systemic therapy for early stage TNBC
  Cases CME course
• Topic 28
  Local therapy for mRCC
  Cases CME course
• Topic 29
  Radiotherapy for early breast cancer
  Cases CME course
• Topic 30
  Management of HER2+ MBC
  Cases CME course
• Topic 31
  Brain metastases in patients with HER2+ breast cancer
  Cases CME course
• Topic 32
  CDK4/6 inhibitors for everyone? Treatment strategies in HR+ HER2- advanced breast cancer
  Cases CME course
• Topic 33
  Theragnostic testing – choosing the right therapy in mTNBC
  Cases CME course
• Topic 34
  Challenges in high-risk NMIBC
  Cases CME course